No results for ‘’
Dr Lal Pathlabs Ltd
₹1693.30
(0.35%)
Tue, 21 Jul 2026, 06:47 pm
Health Services
Medical/Nursing Services
24.5KDr Lal Pathlabs Share Price Live Chart
1 Day
(0.35%)
No Result Found
Summary
Market Cap (in Cr)
26817.85
Net Profit (in Cr)
492.25
P/B
9.53
Sector P/E
58.57
P/E
42.52
EV/EBITDA
25.39
Debt/Equity (Industry)
0.18
Interest Cover (Industry)
12.19
ROCE (Industry)
17.69
RONW (Industry)
14.86
ROE
24.48
ROCE
29.22
Debt/Equity
0.10
EPS (TTM)
31.48
Dividend Yield
1.53
Book Value
149.62
Interest Cover
29.01
Analysis
all
- Dividends paid are well covered by earnings (2.3x coverage).
- Dividends after 3 years are expected to be well covered by earnings (3.9x coverage).
- Dr. Lal PathLabs's earnings growth is expected to exceed the low risk savings rate of 7.2%.
- Dr. Lal PathLabs's earnings are expected to increase by more than the low risk growth rate in 3 years time.
- Dr. Lal PathLabs is expected to efficiently use shareholders’ funds in the future (Return on Equity greater than 20%).
- Dividend payments have increased, but Dr. Lal PathLabs only paid a dividend in the past 4 years.
- Whilst dividend payments have been stable, Dr. Lal PathLabs has been paying a dividend for less than 10 years.
- Dr. Lal PathLabs's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Dr. Lal PathLabs's dividend is below the markets top 25% of dividend payers in India (3.08%).
- Cash flow for Dr. Lal PathLabs is expected to increase but not above the 50% threshold in 2 years time.
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 53.21 | 53.22 | 53.22 | 53.79 | 53.91 |
| FII | 17.18 | 20.29 | 21.86 | 21.68 | 23.91 |
| DII | 21.38 | 19.21 | 18.49 | 17.91 | 16.08 |
| Public | 8.22 | 7.28 | 6.44 | 6.62 | 6.10 |
| Government | 0.01 | 0.01 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 2255.57 | 1952.67 | 1799.43 | 1649.77 | 1496.53 | 1346.87 | 1043.97 |
| Fibonacci | 1952.67 | 1836.96 | 1765.47 | 1649.77 | 1534.06 | 1462.57 | 1346.87 |
| Camarilla | 1729.50 | 1701.73 | 1673.97 | 1649.77 | 1618.43 | 1590.67 | 1562.90 |
Pivots Level: Classic
R3
+605.80
2255.57
R2
+302.90
1952.67
R1
+149.67
1799.43
S1
-153.23
1496.53
S2
-302.90
1346.87
S3
-605.80
1043.97
Moving Average
Period
Value
10-EMA
1699.05
20-EMA
1682.03
30-EMA
1663.88
50-EMA
1628.39
100-EMA
1569.70
200-EMA
1526.45
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 30 Apr 2026 | agm | ||
| 30 Apr 2026 | dividend | ₹4.00 Dividend /Share | 26 Jun 2026 |
| 30 Apr 2026 | board-meetings | Accounts, Quarterly Results | |
| 30 Jan 2026 | dividend | ₹3.50 Dividend /Share | 05 Feb 2026 |
| 30 Jan 2026 | board-meetings | Quarterly Results | |
| 05 Jan 2026 | dividend | Interim Dividend - Rs. - 3.5 | 05 Feb 2026 |
| 12 Dec 2025 | bonus | 1:1 Bonus Issue of Equity Shares | 12 Dec 2025 |
| 19 Nov 2025 | bonus | Bonus issue 1:1 | 19 Dec 2025 |
| 31 Oct 2025 | dividend | ₹7.00 Dividend /Share | 07 Nov 2025 |
| 31 Oct 2025 | board-meetings | Quarterly Results, Half Yearly Results, Interim Dividend, Bonus Issue |
Peer Comparison
Dr Lal Pathlabs Ltd
Fortis Healthcare Ltd
Max Healthcare Institute Ltd
Narayana Hrudayalaya Ltd
Aster DM Healthcare Ltd
Apollo Hospitals Enterprise Ltd
Dr Lal Pathlabs Ltd About
Dr. Lal PathLabs is engaged in the business of running laboratories for carrying out pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations.
Industry
Healthcare
Founded
1995
Headquarters
CEO
Arvind Lal
Employees
Contact
Website
http://www.lalpathlabs.com
cs@lalpathlabs.com
Phone
91-011-3024 4149
Location
E-2 Block Sector 18, Rohini, New Delhi, New Delhi, 110085
Dr Lal Pathlabs Ltd Company History
| Year | History |
|---|---|
| 2017 |
|
| 2018 |
|
| 2021 |
|
| 2023 |
|
| 2024 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| GOLDMAN SACHS BANK EUROPE SE - ODI | block | Buy | 33414 | 3160 | 20 Oct 2025 |
| GOLDMAN SACHS (SINGAPORE) PTE - ODI | block | Sell | 33414 | 3160 | 20 Oct 2025 |
| MULTI-MANAGER ICVC | bulk | Sell | 434943 | 2997.11 | 06 Jan 2025 |
| ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 12949 | 2550.9 | 25 Oct 2022 |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 69319 | 2550.9 | 25 Oct 2022 |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 69319 | 2550.9 | 25 Oct 2022 |
| ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 12949 | 2550.9 | 25 Oct 2022 |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 69250 | 2377.5 | 17 Oct 2022 |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 69250 | 2377.5 | 17 Oct 2022 |
| ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 12934 | 2377.5 | 17 Oct 2022 |